Article Information
History
- July 5, 2021.
Article Versions
- Version 1 (May 11, 2021 - 17:18).
- Version 2 (May 14, 2021 - 08:31).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Anar Sanjaykumar Kothary1,2,*,
- Caroline Mahendra1,*,
- Mingchen Tan1,
- Eunice Jia Min Tan3,
- Jacelyn Phua Hong Yi1,
- Gabriella1,
- Tan Xin Hui Jocelyn1,
- Jessline Stephanie Haruman1,
- Zhihao Tan1,2,
- Chun Kiat Lee3,
- Alexander Lezhava2,
- Benedict Yan3,4 and
- Astrid Irwanto1,5,#
- 1Nalagenetics Pte Ltd, Singapore, Singapore
- 2Center for Genome Diagnostics, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore
- 3Department of Laboratory Medicine, National University Health System, Singapore
- 4Stronghold Diagnostics Lab, Agency for Science, Technology and Research, Singapore
- 5Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore
- ↵#corresponding author: astrid{at}nalagenetics.com
↵* equal contribution
Posted July 05, 2021.
Validation of a multi-gene qPCR-based pharmacogenomics panel across major ethnic groups in Singapore and Indonesia
